20 Million Americans Have Undiagnosed Thyroid Disease. And Most Are Women
An estimated 20 million Americans have some form of thyroid disease, and up to 60 percent of them don’t know it, according to the American Thyroid Association. Figures consistent with NIH research on thyroid dysfunction prevalence in the U.S. adult population. Of those diagnosed, women are five to eight times more likely than men to have a thyroid condition, yet practitioners consistently report that women with textbook hypothyroid symptoms are routinely told their labs are “normal” and sent home without treatment. Dr. Amie Hornaman, thyroid specialist and founder of the Advanced Thyroid & Hormone Clinic, says the problem isn’t the labs. It’s how they’re being used. And who’s getting left behind because of it.
Key Facts: Up to 60% of people with thyroid disease are undiagnosed, according to the American Thyroid Association Women are 5-8x more likely than men to develop a thyroid condition (National Institute of Diabetes and Digestive and Kidney Diseases, NIDDK) A 2021 NIH-published study in Frontiers in Endocrinology found that a significant proportion of patients on levothyroxine (Synthroid) continue reporting persistent symptoms despite labs returning to reference range. Indicating standard TSH-only protocols don’t resolve symptoms for every patient The standard TSH reference range (0.5-4.5 mIU/L) was established to detect overt thyroid disease. Not to define optimal function for individual patients Dr. Hornaman’s clinic operates via telemedicine across all 50 states, removing geographic barriers for patients who can’t access functional thyroid care locally The clinic’s FIXXR supplement line, at-home blood panel testing, and virtual consultations give patients a full care pathway without a single in-person referral required
Women who’ve spent years cycling through doctors, collecting “normal” lab results, and accumulating symptoms that don’t have an official diagnosis aren’t outliers. They’re the majority. The NIH’s National Institute of Diabetes and Digestive and Kidney Diseases identifies hypothyroidism as one of the most underdiagnosed conditions in women over 40. And the gap between “technically in range” and “actually functioning well” is where millions of patients fall through. The clinical mechanism isn’t mysterious. TSH measures the brain’s signal to the thyroid. Not what the thyroid actually delivers to cells. A patient can have a TSH of 2.5, look fine on paper, and still have significant conversion issues where T4 isn’t converting to the active T3 the body needs to regulate metabolism, energy, and cognitive function. Dr. Hornaman’s approach uses a full thyroid panel, TSH, Free T3, Free T4, Reverse T3, and thyroid antibodies, alongside symptom assessment and, where indicated, bioidentical hormone evaluation. That’s not an alternative to labs. It’s using labs correctly. Consider a typical patient at this clinic: a 47-year-old woman who’s been on levothyroxine for three years, whose TSH sits at 1.8, and whose doctor considers her case closed. She’s still gaining weight. She can’t get through the afternoon without crashing. Her hair is thinning and her doctor calls it aging. When a full panel is run, her Free T3 is in the low-normal range and her Reverse T3 is elevated. A pattern consistent with poor thyroid hormone conversion. That patient doesn’t need a different attitude about her symptoms. She needs a different protocol. This is a common presentation at the clinic, and it’s exactly the scenario that standard TSH-based treatment misses. It’s worth naming the limitation plainly: telemedicine thyroid care isn’t right for every clinical situation. Patients with newly discovered thyroid nodules, suspected thyroid cancer, or complex multi-system disease may need in-person imaging and specialist co-management. Dr. Hornaman refers out when that’s the right call. But for the enormous population of women who’ve been dismissed, who have real symptoms, real dysfunction, and no diagnosis, waiting for conventional medicine to catch up is the most expensive decision they can make.
Executive Quotes Dr. Amie Hornaman, Thyroid Specialist and Founder, Advanced Thyroid & Hormone Clinic: “The TSH reference range was designed to catch severe thyroid disease. Not to define what optimal looks like for a 45-year-old woman trying to function. When a doctor looks at a TSH of 2.0 and says ‘you’re fine,’ they’re answering a completely different question than the one the patient is asking. She’s asking: why do I feel like this? The lab wasn’t built to answer that. That’s not the patient’s fault, and it’s not even the lab’s fault. It’s a systems problem. And it has a solution.” Dr. Amie Hornaman: “The data on undiagnosed thyroid disease has been sitting in published research for decades. Twenty million people. Sixty percent don’t know. Women hit five to eight times harder than men. And the answer we’ve collectively landed on is: keep using the same TSH cutoff and tell people their results are normal. That’s not medicine. That’s paperwork. What actually moves the needle is treating the person, symptoms included, not just the number on the printout.”
About Dr. Amie Hornaman – Advanced Thyroid & Hormone Clinic
Dr. Amie Hornaman is a thyroid specialist and functional medicine practitioner who was herself misdiagnosed for years before finding the root cause of her own thyroid dysfunction. An experience that now drives her clinical approach. Through her virtual clinic, she offers personalized thyroid treatment, bioidentical hormone replacement therapy, at-home lab testing, and her proprietary FIXXR supplement line to patients across all 50 states. She is the author of The Thyroid Fix and host of a top-ranked health podcast, and she’s built her practice on a single premise: your symptoms are data, and they deserve to be treated that way.
Media Contact
Company Name: Dr. Amie Hornaman
Contact Person: Dr. Amie Hornaman
Email: Send Email
City: Florida
Country: United States
Website: https://dramie.com/
